Combination of Stem Cell Mobilized by Granulocyte-Colony Stimulating Factor and Human Umbilical Cord Matrix Stem Cell: Therapy of Traumatic Brain Injury in Rats
- سال انتشار: 1390
- محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 14، شماره: 4
- کد COI اختصاصی: JR_IJBMS-14-4_004
- زبان مقاله: انگلیسی
- تعداد مشاهده: 167
نویسندگان
Cellular & Molecular Research Center, Tehran University of Medical Sciences, Tehran, Iran
Cellular & Molecular Research Center, Tehran University of Medical Sciences, Tehran, Iran
Cellular & Molecular Research Center, Tehran University of Medical Sciences, Tehran, Iran
Cellular & Molecular Research Center, Tehran University of Medical Sciences, Tehran, Iran
Cellular & Molecular Research Center, Tehran University of Medical Sciences, Tehran, Iran
Department of Anatomy, Tehran University of Medical Science, Tehran, Iran
Department of Anatomy, Tehran University of Medical Science, Tehran, Iran
Department of Immunology, Tehran University of Medical Sciences, Tehran, Iran
Department of Biotechnology and Bioscience, Milano-Bicocca University, Milan, Italy
Department of Anatomy, Tehran University of Medical Science, Tehran, Iran
Department of Anatomy, Tehran University of Medical Science, Tehran, Iran
Department of physiology, Tehran University of Medical Sciences, Tehran, Iran
چکیده
Objective(s) Clinical studies of treating traumatic brain injury (TBI) with autologous adult stem cells led us to examine the impression of a combination therapy. This was performed by intravenous injection of human umbilical cord matrix stem cell (hUCMSC-Wharton,s jelly stem cell) with bone marrow cell mobilized by granulocytecolony stimulating factor (G-CSF) in rats injured with cortical compact device. Materials and Methods Adult male Wistar rats (n= ۵۰) were injured with controlled cortical impact device and divided into five groups. All injections were performed ۱ day after injury into the tail veins of rats. Neurological functional evaluation of animals was performed before and after injury using modified neurological severity scores (mNSS). Animals were sacrificed ۴۲ days after TBI and brain sections were stained by Brdu immunohistochemistry. Results Statistically significant improvement in functional outcome was observed in treatment groups when compared with control (P< ۰.۰۱). mNSS showed no significant differences among the hUCMSC and G-CSF treated groups at any time point (end of trial). Rats with hUCMSC + G-CSF treatment had a significant improvement on mNSS at ۵ and ۶ week compared to other treatment group (P< ۰.۰۱). Conclusion Histological analysis in G-CSF+ hUCMSC treated traumatic rats exhibited significant increase in numbers of Brdu immunoreactive cells in their traumatic core compared with other labeled group.کلیدواژه ها
Combine Therapy, G-CSF, Stem cell, TBI, Whartons jellyاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.